DispersinB Cleanser for Acne

N/A

Waitlist Available

Led By Prinicipal Investigator

Research Sponsored by Kane Biotech Inc

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to week 12

Awards & highlights

No Placebo-Only Group

Summary

This trial will study the effectiveness and safety of DispersinB Acne Cleanser in treating acne in adults. They will compare the right and left side of the face to see how well the product works. They will look at how many subjects have clear skin after 12 weeks and count the number of acne lesions on each side of the face. Participants will use the DispersinB Acne Cleanser on one side of the face and a benzoyl peroxide wash on the other side for daily use.

Who is the study for?

This trial is for adults with mild to moderate acne vulgaris. Participants will treat one side of their face with DispersinB Acne Cleanser and the other side with a standard treatment, allowing researchers to compare results directly on each person.

What is being tested?

The study tests if DispersinB Acne Cleanser can improve acne when used alongside Benzoyl Peroxide compared to using Benzoyl Peroxide alone. It's an intra-individual comparison over 12 weeks, focusing on how many people achieve clear skin and the change in number of acne lesions.

What are the potential side effects?

Potential side effects may include skin irritation, dryness, or allergic reactions from either DispersinB Acne Cleanser or Benzoyl Peroxide. These are common in topical acne treatments.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in inflammatory and noninflammatory lesion count

Success rate per half-face

Secondary study objectives

Local tolerability

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: intra-individual Split-face comparisonExperimental Treatment1 Intervention

Subjects will complete baseline assessments and be randomized (left face versus right face) to apply DispersinB Acne Cleanser over at 12-week treatment period, for an intra-individual, split-face comparison. Subjects will use the DispersinB Acne Cleanser on the assigned facial side for 5 minutes and then will use the provided 4% Benzoyl peroxide facial wash to wash entire face for daily (evening) use.

Do I qualify?Apply below to find out